Nasal High-Flow (NHF) Improves Ventilation in Patients with Interstitial Lung Disease (ILD)—A Physiological Study

Nasal High-Flow (NHF) Improves Ventilation in Patients with Interstitial Lung Disease (ILD)—A Physiological Study

Introduction: Acute hypercapnic respiratory failure has a poor prognosis in patients with interstitial lung disease (ILD). Recent data demonstrated a positive effect of nasal high-flow (NHF) in patients with acute hypoxemic respiratory failure. Preliminary data also show benefits in several hypercap...

Full description

Bibliographic Details
Main Authors:	Jens Bräunlich, Marcus Köhler, Hubert Wirtz
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Journal of Clinical Medicine
Subjects:	nasal high-flow NHF hypercapnia lung fibrosis ILD breathing pattern
Online Access:	https://www.mdpi.com/2077-0383/12/18/5853

Similar Items

Nasal highflow improves ventilation in patients with COPD
by: Bräunlich J, et al.
Published: (2016-05-01)

Nasal high-flow in acute hypercapnic exacerbation of COPD
by: Bräunlich J, et al.
Published: (2018-11-01)

Safety and efficacy of high flow nasal canula in patients with mild hypercapnia
by: Mohammed A. Ibrahim, et al.
Published: (2023-11-01)

Effect of Nasal High Flow (NHF) on Right Heart Function in Stable Patients with Pulmonary Hypertension of Different WHO Classes
by: Jens Bräunlich, et al.
Published: (2024-03-01)

Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent
by: Jens Bräunlich, et al.
Published: (2018-01-01)

Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD
by: Bräunlich J, et al.
Published: (2019-07-01)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
by: Elisabetta Zanatta, et al.
Published: (2023-05-01)

Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
by: Rajesh Swarnakar, et al.
Published: (2022-01-01)

Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
by: Katharina Buschulte, et al.
Published: (2024-01-01)

Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
by: Katharina Buschulte, et al.
Published: (2024-03-01)

Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
by: Mona Nili, et al.
Published: (2022-04-01)

The inhibition and resistance mechanisms of actinonin, isolated from marine Streptomyces sp. NHF165, against Vibrio anguillarum
by: Na Yang, et al.
Published: (2016-09-01)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
by: Julien Guiot, et al.
Published: (2022-04-01)

Novel Disease but responding to an Old Drug: Role of Prolonged Corticosteroid Use in Prevention and Treatment of Post-Covid Interstitial Lung Disease (PC-ILD)
by: Muhammad Waseem, et al.
Published: (2022-06-01)

Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study
by: Kyung-In Joung, et al.
Published: (2023-03-01)

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World
by: Markus Polke, et al.
Published: (2021-09-01)

Multi-detector CT (MDCT) evaluation in interstitial lung disease (ILD): Comparison of MinIP and volumetric high resolution CT (HRCT) images
by: Youssriah Y. Sabri, et al.
Published: (2017-03-01)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01)

A Cross-Sectional Survey of Pulmonologists Working at Non-ILD Centers in the United States
by: Biehl R, et al.
Published: (2023-07-01)

Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases
by: Yunxin Lai, et al.
Published: (2021-11-01)

Hook effect and serum KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
by: Emmy Hermiyanti Pranggono, et al.
Published: (2021-10-01)

Correlation between serum KL-6 level and severity of SARD-related ILD
by: Emmy Pranggono, et al.
Published: (2022-04-01)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
by: Valentina Agnese Ferraro, et al.
Published: (2020-12-01)

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-08-01)

Bronchiectasis as co morbidity with COPD or ILD: complex interactions and severe consequences
by: Manal SH. Elhussini, et al.
Published: (2023-03-01)

Closed–loop oxygen control improves oxygenation in pediatric patients under high–flow nasal oxygen—A randomized crossover study
by: Ozlem Sandal, et al.
Published: (2022-11-01)

Effects of high-flow nasal cannula in patients with mild to moderate hypercapnia: a prospective observational study
by: Kyung Hun Nam, et al.
Published: (2021-08-01)

Bridges of Pulmonology 2023 proceedings: Highlights in the field of interstitial lung diseases
by: Vasilina Sotiropoulou, et al.
Published: (2024-03-01)

Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation
by: M. Vitacca, et al.
Published: (2004-06-01)

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
by: M. C. Schimmelpennink, et al.
Published: (2022-06-01)

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
by: Amy Hajari Case
Published: (2022-03-01)

The Patterns of pulmonary manifestations in ILDs in rheumatoid arthritis
by: Wael Abdelmohsen Abo zaid, et al.
Published: (2022-07-01)

Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report
by: Tsai-Hung Yen, et al.
Published: (2021-12-01)

Evaluating the diagnostic and therapeutic significance of KL-6 in patients with interstitial lung diseases
by: Ting Wang, et al.
Published: (2024-04-01)

L-DOPA Improves Ventilation but Not the Ventilatory Response to Hypercapnia in a Reserpine Model of Parkinson’s Disease
by: Monika Jampolska, et al.
Published: (2023-05-01)

Lung Ultrasound in the Screening of Pulmonary Interstitial Involvement Secondary to Systemic Connective Tissue Disease: A Prospective Pilot Study Involving 180 Patients
by: Natalia Buda, et al.
Published: (2021-09-01)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
by: Lutz B. Jehn, et al.
Published: (2023-02-01)

Role of IOS in evaluation of patients with interstitial lung diseases
by: B.A. Naglaa, et al.
Published: (2016-10-01)

Impaired ventilatory and thermoregulatory responses to hypoxic stress in newborn Phox2b heterozygous knockout mice
by: Nelina eRamanantsoa, et al.
Published: (2011-09-01)

The Role of High-Flow Nasal Cannula Oxygen Therapy in Exercise Testing and Pulmonary Rehabilitation: A Review of the Current Literature
by: Claudio Candia, et al.
Published: (2023-12-01)